C4 Therapeutics Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for C4 Therapeutics Inc. C4 Therapeutics Inc has 14 trademark applications. The latest application filed is for "C4 THERAPEUTICS"
| Patent Application | Date |
|---|---|
| DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT 20220289738 - 17/576582 Norcross; Roger ; et al. | 2022-09-15 |
| DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION 20220251061 - 16/874475 Phillips; Andrew J. ; et al. | 2022-08-11 |
| COMPOUNDS FOR TARGETED DEGRADATION OF BRD9 20220098194 - 17/541035 Nasveschuk; Christopher G. ; et al. | 2022-03-31 |
| COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1 20210198256 - 17/192634 Nasveschuk; Christopher G. ; et al. | 2021-07-01 |
| SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION 20210106688 - 16/882236 Phillips; Andrew J. ; et al. | 2021-04-15 |
| NCAGE Code | 7ZW60 | C4 THERAPEUTICS INC |
| CAGE Code | 7ZW60 | C4 THERAPEUTICS INC |
| SEC | 0001662579 | C4 Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 